Q Line Biotech Ltd vs Shankara Buildpro Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 24, 2026

Key Highlights

The Latest Trading Price of Q-Line Biotech Ltd is ₹ 529.55 as of 23 Oct 15:30 . The P/E Ratio of Q-Line Biotech Ltd changed from 0 on March 2023 to 0 on March 2026 . This represents a CAGR of 0.0% over 4 yearsThe P/E Ratio of Shankara Buildpro Ltd changed from 18.1 on March 2026 to 18.1 on March 2026 . This represents a CAGR of 0.00% over 1 years The Market Cap of Q-Line Biotech Ltd changed from ₹ 0 crore on March 2023 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 4 yearsThe Market Cap of Shankara Buildpro Ltd changed from ₹ 2318 crore on March 2026 to ₹ 2318 crore on March 2026 . This represents a CAGR of 0.00% over 1 years The revenue of Q-Line Biotech Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 110.94 crore. This represent the decline of -100% The revenue of Shankara Buildpro Ltd for the Jun '26 is ₹ 1890 crore as compare to the Mar '26 revenue of ₹ 1996 crore. This represent the decline of -5.33% The ebitda of Q-Line Biotech Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 33.57 crore. This represent the decline of -100% The ebitda of Shankara Buildpro Ltd for the Jun '26 is ₹ 61.58 crore as compare to the Mar '26 ebitda of ₹ 70.08 crore. This represent the decline of -12.13% The net profit of Q-Line Biotech Ltd changed from ₹ 17.38 crore to ₹ 0 crore over 3 quarters. This represents a CAGR of -100.00% The net profit of Shankara Buildpro Ltd changed from ₹ 16.63 crore to ₹ 35.78 crore over 9 quarters. This represents a CAGR of 40.57% The Dividend Payout of Q-Line Biotech Ltd is 0 % as of March 2024 .The Dividend Payout of Shankara Buildpro Ltd is 0 % as of March 2024.

About Q-Line Biotech Ltd

Q-Line Biotech Limited was originally incorporated as 'POCT Services Private Limited' on November 10, 2010 as a Private limited company dated November 10, 2010 issued by the Assistant Registrar of Companies, Uttar Pradesh and Uttarakhand.
Subsequently, the name of Company was changed to 'Q-Line Biotech Private Limited on July 23, 2021.
Further, Company was converted from a private company to public company and the name of Company was changed to 'Q-Line Biotech Limited', via fresh certificate of incorporation dated March 08, 2025 issued by Central Processing Centre. The Company is engaged in the business of developing, manufacturing and marketing of diverse range of reagents (including kits and POC devices) & consumables and manufacturing, importing, distribution/supply of diagnostic equipment for different diagnostic healthcare needs.

About Shankara Buildpro Ltd

Shankara Buildpro Limited was incorporated as 'Shankara Buildpro Private Limited' on October 13, 2023, as a wholly owned subsidiary of SBPL, in the state of Karnataka.
Further, pursuant to conversion of Company from private company into public company, the name of the Company was changed to 'Shankara Buildpro Limited' vide Certificate of Incorporation dated November 30, 2023.
The Company was incorporated with the primary focus on engaging in retailing, trading, warehousing, wholesale distribution and ecommerce activities related to all building materials. The Trading Business of erstwhile promoter SBPL got transferred into the Company as a going concern. pursuant to the Scheme of Arrangement for Demerger with effect from April 01, 2024, making it effective from 9th September 2025.
Prior to transfer of Trading Business from SBPL to Company, the Company had not commenced revenue-generating operations and did not have any income from operations.

FAQs for the comparison of Q-Line Biotech Ltd and Shankara Buildpro Ltd

Which company has a larger market capitalization, Q-Line Biotech Ltd or Shankara Buildpro Ltd?

Market cap of Q-Line Biotech Ltd is 1,235 Cr while Market cap of Shankara Buildpro Ltd is 2,634 Cr

What are the key factors driving the stock performance of Q-Line Biotech Ltd and Shankara Buildpro Ltd?

The stock performance of Q-Line Biotech Ltd and Shankara Buildpro Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Q-Line Biotech Ltd and Shankara Buildpro Ltd?

As of October 25, 2026, the Q-Line Biotech Ltd stock price is INR ₹529.55. On the other hand, Shankara Buildpro Ltd stock price is INR ₹217.3.

How do dividend payouts of Q-Line Biotech Ltd and Shankara Buildpro Ltd compare?

To compare the dividend payouts of Q-Line Biotech Ltd and Shankara Buildpro Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.